Clinical Trial Update: An Exploratory Study of NBI-34060 Capsules and Next Day Functioning [Phase 3]

View source ↗

Summary

A Phase 3 exploratory trial of NBI-34060 for insomnia has been withdrawn. No results are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• NBI-34060

Snippet

Sponsor: Neurocrine Biosciences | Conditions: Insomnia | Phase 3 | Status: WITHDRAWN